Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Patent
1995-06-07
1997-01-21
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
A61K 4900
Patent
active
055957226
ABSTRACT:
A method for identifying a compound that is a TGF-beta activator or production stimulator is provided.
REFERENCES:
patent: Re32944 (1989-06-01), Harita et al.
patent: 3940422 (1976-02-01), Harita et al.
patent: 4070484 (1978-01-01), Harita et al.
patent: 4093709 (1978-06-01), Choi et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez
patent: 4235988 (1980-11-01), Fildes et al.
patent: 4323707 (1982-04-01), Suarez
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones
patent: 4442119 (1984-04-01), Magarian et al.
patent: 4512762 (1985-04-01), Spears
patent: 4675189 (1987-06-01), Kent et al.
patent: 4824436 (1989-04-01), Wolinsky
patent: 4826672 (1989-05-01), Milius et al.
patent: 4835002 (1989-05-01), Wolf et al.
patent: 4839155 (1989-06-01), McCague
patent: 4859585 (1989-08-01), Sonnenschein et al.
patent: 4879315 (1989-11-01), Magarian et al.
patent: 4929602 (1990-05-01), Harker et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4968350 (1990-11-01), Bindschaedler et al.
patent: 4990538 (1991-02-01), Harris et al.
patent: 4997652 (1991-03-01), Wong
patent: 5015666 (1991-05-01), Magarian et al.
patent: 5026537 (1991-06-01), Dadonna et al.
patent: 5032679 (1991-07-01), Brandley et al.
patent: 5043335 (1991-08-01), Kleinschroth
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5049132 (1991-09-01), Shaffer et al.
patent: 5053033 (1991-10-01), Clarke
patent: 5075321 (1991-12-01), Schreiber
patent: 5098903 (1992-03-01), Magarian et al.
patent: 5102402 (1992-04-01), Dror et al.
patent: 5112305 (1992-05-01), Barath et al.
patent: 5114719 (1992-05-01), Sabel et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5120535 (1992-06-01), Marquardt et al.
patent: 5140012 (1992-08-01), McGovern et al.
patent: 5166143 (1992-11-01), Ondetti et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5180366 (1993-01-01), Woods et al.
patent: 5185260 (1993-02-01), Crissman et al.
patent: 5189046 (1993-02-01), Burch et al.
patent: 5189212 (1993-02-01), Ruenitz
patent: 5192525 (1993-03-01), Yang et al.
patent: 5208019 (1993-05-01), Hansson et al.
patent: 5213576 (1993-05-01), Abiuso et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5216126 (1993-06-01), Cox et al.
patent: 5219548 (1993-06-01), Yang et al.
patent: 5221620 (1993-06-01), Purchio et al.
patent: 5226430 (1993-07-01), Spears et al.
patent: 5229495 (1993-07-01), Ichijo et al.
patent: 5238714 (1993-08-01), Wallace et al.
patent: 5238950 (1993-08-01), Clader et al.
patent: 5242397 (1993-09-01), Barath et al.
patent: 5248764 (1993-09-01), Flanagan et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5268358 (1993-12-01), Fretto
patent: 5270047 (1993-12-01), Kaufman et al.
patent: 5280016 (1994-01-01), Conrad et al.
patent: 5280109 (1994-01-01), Miyazono et al.
patent: 5283257 (1994-02-01), Gregory et al.
patent: 5284763 (1994-02-01), Derynk et al.
patent: 5284869 (1994-02-01), Bisaccia et al.
patent: 5288711 (1994-02-01), Mitchell et al.
patent: 5296492 (1994-03-01), Shiozawa et al.
patent: 5304325 (1994-04-01), Kaufman et al.
patent: 5304541 (1994-04-01), Purchio et al.
patent: 5308622 (1994-05-01), Casscells et al.
patent: 5308862 (1994-05-01), Ohlstein
patent: 5314679 (1994-05-01), Lewis et al.
patent: 5316766 (1994-05-01), Baldus et al.
patent: 5324736 (1994-06-01), Magarian et al.
patent: 5326757 (1994-07-01), Demopoulos
patent: 5328471 (1994-07-01), Slepian
patent: 5332584 (1994-07-01), Scher et al.
patent: 5340925 (1994-08-01), Lioubin et al.
patent: 5346702 (1994-09-01), Na et al.
patent: 5346993 (1994-09-01), Miyazono et al.
patent: 5354562 (1994-10-01), Platz et al.
patent: 5354774 (1994-10-01), Deckelbaum et al.
patent: 5354801 (1994-10-01), O'Toole et al.
patent: 5356713 (1994-10-01), Charmot et al.
patent: 5362424 (1994-11-01), Lee et al.
patent: 5364632 (1994-11-01), Benita et al.
patent: 5380716 (1995-01-01), Conrad et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5385935 (1995-01-01), Tamari et al.
patent: 5389670 (1995-02-01), Fontana
patent: 5391557 (1995-02-01), Cullinan et al.
patent: 5393763 (1995-02-01), Black et al.
patent: 5393772 (1995-02-01), Yue et al.
patent: 5393785 (1995-02-01), Labrie et al.
patent: 5395842 (1995-03-01), Labrie et al.
patent: 5418252 (1995-05-01), Willaims
patent: 5424331 (1995-06-01), Shlyankevich
patent: 5426123 (1995-06-01), Fontana
patent: 5434166 (1995-07-01), Glasebrook
patent: 5436243 (1995-07-01), Sachs et al.
patent: 5439923 (1995-08-01), Cullinan
patent: 5439931 (1995-08-01), Sales
patent: 5441947 (1995-08-01), Dodge et al.
patent: 5441964 (1995-08-01), Bryant et al.
patent: 5441965 (1995-08-01), Sall et al.
patent: 5441966 (1995-08-01), Dodge
patent: 5441986 (1995-08-01), Thompson
patent: 5444164 (1995-08-01), Purchio et al.
patent: 5445941 (1995-08-01), Yang
patent: 5446053 (1995-08-01), Keohane
patent: 5446070 (1995-08-01), Mantelle
patent: 5447941 (1995-09-01), Zuckerman
patent: 5451589 (1995-09-01), Dodge
patent: 5451590 (1995-09-01), Dodge
patent: 5453436 (1995-09-01), Ohlstein
patent: 5453442 (1995-09-01), Bryant et al.
patent: 5455275 (1995-10-01), Fontana
patent: 5457113 (1995-10-01), Cullinan et al.
patent: 5457116 (1995-10-01), Black et al.
patent: 5457117 (1995-10-01), Black et al.
patent: 5460807 (1995-10-01), Cardin et al.
patent: 5461064 (1995-10-01), Cullinan
patent: 5461065 (1995-10-01), Black et al.
patent: 5462937 (1995-10-01), Cullinan et al.
patent: 5462949 (1995-10-01), Jones et al.
patent: 5462950 (1995-10-01), Fontana
patent: 5466810 (1995-11-01), Godfrey
patent: 5470883 (1995-11-01), Stromberg
patent: 5472985 (1995-12-01), Grainger et al.
patent: 5498775 (1996-03-01), Novak et al.
Allemann et al., "Distribution, kinetics, and elimination of radioactivity after intravenous and intramuscular injection of 14C-savoxepoine loaded poly (D,L-lactic acid) nanospheres to rats," J. Controlled Release, 29, 97-104 (1994).
Allemann et al., "Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: purification of an injectable dosage form," Eur. J. Pherm. Biopharm., 39, 13-18 (1993).
Anderson et al., "Effects of Acetate Dialysate on Transforming Growth Factor .beta..sub.1 -interleukin and .beta..sub.2 -microglobulin Plasma Levels," Kidney International, 40, 1110-1117 (Oct. 1991).
Anker et al., "Plasma Levels of the Atherogenic Amino Acid Homocysteine in Post-Menopausal Women with Breast Cancer Treated with Tamoxifen," Int. J. Cancer, 60, 365-368 (1995).
Assoian et al., "Type .beta. Transforming Growth Factor in Human Platelets: Release During Platelet Degranulation and Action on Vascular Smooth Muscle Cells," J. Cell. Biol., 102, 1217-1223 (Apr. 1986).
Attwood et al., "A Light Scattering Study on Oil-in-Water Microemulsions", Int'l J. Pharm., 52, 165-171 (1989).
Bagdade et al., "Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid Composition," J. Clinical Endocrinology and Metabolism, 70, 1132-1135 (1990).
Barath et al., "Low Dose of Antitumor Agents Prevents Smooth Muscle Cell Proliferation After Endothelial Injury", JACC, 13, p. 252A, Abstract No. 252A (Feb. 1989).
Beck et al., "Poly(DL-lactide-co-glycolide)
orethisterone Microcapsules: An Injectible Biodegradable Contraceptive", Biol. Reprod., 28, 186-195 (1983).
Benita et al., "Submicron Emulsions as Colloidal Drug Carriers for Intravenous Administration Comprehensive Physiochemical Characterization," J. Pharmaceutical Sciences, 82, 1069-1078 (Nov. 1993).
Bertelli et al., "Adjuvant Tamoxifen in Primary Breast Cancer: Influence on Plasma Lipids and Antithrombin III Levels," Breast Cancer Res. and Treatment, 12, 307-310 (1988).
Bier et al., "Arterial Remodeling: Importance in Primary Versus Restenotic Lesions," JACC, p. 139A, Abstract No. 875-96 (Feb. 1994).
Bluming et al., "Hormone Replacement Therapy: Benefits and Risks for the General Postmenopausal Female Population and for Women with a History of Previously Treated Breast Cancer," Seminars in Oncology, 20 662-674 (Dec. 1993).
"Breast Cancer Prevention Trial Should Resume, ODAC Says," The Breast Cancer Letter, 20, 4-5 (Jun
Grainger David J.
Metcalfe James C.
Henley III Raymond
NeoRx Corporation
LandOfFree
Method for identifying an agent which increases TGF-beta levels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying an agent which increases TGF-beta levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying an agent which increases TGF-beta levels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2322335